Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Palmoplantar Psoriasis”

46 trials

Showing 20 of 46 results

Large-scale testing (Phase 3)Study completedNCT01765985
What this trial is testing

Treatment of Palmoplantar Psoriasis With Low Doses Interferential Current

Who this might be right for
Psoriasis Palm & Soles
Pr PASSERON 36
Not applicableStudy completedNCT01780857
What this trial is testing

Immune Signature of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Baylor Research Institute 30
Large-scale testing (Phase 3)Study completedNCT04713592
What this trial is testing

Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement

Who this might be right for
Psoriasis
AbbVie 174
Testing effectiveness (Phase 2)Looking for participantsNCT07013201
What this trial is testing

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
LEO Pharma 135
Not applicableStudy completedNCT04459507
What this trial is testing

A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan

Who this might be right for
Palmoplantar Pustulosis
Janssen Pharmaceutical K.K. 276
Post-approval studies (Phase 4)UnknownNCT04622033
What this trial is testing

Brodalumab in Palmoplantar Psoriasis

Who this might be right for
Palmoplantar Psoriasis
First OC Dermatology 10
Testing effectiveness (Phase 2)Study completedNCT03135548
What this trial is testing

Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients

Who this might be right for
Psoriasis
Boehringer Ingelheim 59
Testing effectiveness (Phase 2)Study completedNCT03633396
What this trial is testing

Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Vanda Pharmaceuticals 59
Large-scale testing (Phase 3)Study completedNCT04451720
What this trial is testing

Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
AbbVie 119
Early research (Phase 1)Study completedNCT03972280
What this trial is testing

Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis

Who this might be right for
Hidradenitis SuppurativaPalmoplantar Pustulosis
CSL Behring 39
Large-scale testing (Phase 3)Study completedNCT00686686
What this trial is testing

Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 23
Testing effectiveness (Phase 2)Study completedNCT04015518
What this trial is testing

Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Boehringer Ingelheim 152
Testing effectiveness (Phase 2)Study completedNCT03988335
What this trial is testing

Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Aristea Therapeutics, Inc. 35
Not applicableNot Yet RecruitingNCT07000630
What this trial is testing

Efficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Peking University First Hospital 25
Large-scale testing (Phase 3)UnknownNCT00811005
What this trial is testing

Fumaric Acid Ester-PUVA Therapy Versus Acitretin -PUVA Therapy in Pustular Palmoplantar Psoriasis

Who this might be right for
Pustular Palmoplantar Psoriasis
Medical University of Vienna 20
Not applicableLooking for participantsNCT04359394
What this trial is testing

International Rare And Severe Psoriasis Expert Network

Who this might be right for
Pustular Psoriasis (PP)
University Hospital, Basel, Switzerland 180
Large-scale testing (Phase 3)Looking for participantsNCT07219420
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
UCB Biopharma SRL 300
Not applicableStudy completedNCT06458868
What this trial is testing

An Open-label Controlled Trial: Effectiveness of Balneotherapy in Palmoplantar Psoriasis and Contact Dermatitis.

Who this might be right for
PsoriasisContact Dermatitis of Hand
Ankara University 140
Testing effectiveness (Phase 2)Study completedNCT01845987
What this trial is testing

The Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantaris Pustulosis
Janssen Pharmaceutical K.K. 49
Large-scale testing (Phase 3)Study completedNCT05174065
What this trial is testing

Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Amgen 176
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation